Investing Profile

Cillian King

VCInvestor

Managing Director at EQT Life Sciences

Your Intro Paths to Cillian King

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Cillian is a member of

Massachusetts Institute of Technology (MIT) Network

18 CONNECTIONS

EQT Group Network

17 CONNECTIONS

EQT Group Network

17 CONNECTIONS

Find Cillian King on

Current Investing Position

EQT Life Sciences Managing Director

Investment Range

$11.0M - $65.0M

Sweet Spot

$25.0M

Investments On Record

Current Fund Size

€260M

Cillian King is on these Sector & Stage Rankings

Cillian King's Investments On Record (1)

Company	StageDateRound Size	Total Raised
QurAlis	Series BMar 2023$88M	$140M
Co-investors: Amy Schulman (Polaris Partners), Jeffrey Moore (MP Healthcare Venture Management), Johannes Fruehauf (Mission BioCapital), Philip Scheltens (EQT Life Sciences), Roel Bulthuis (Syncona Limited), Stephen Thompson (Brandon Capital Partners), Laia Crespo (Sanofi Ventures)

Cillian King's Experience

Board Member QurAlis2023 - Present

Managing Director EQT Group2022 - Present

Board Member Muna Therapeutics2021 - Present

Board Member Sairopa B.V.2021 - Present

Founder Koala Life Sciences2017 - Present

Investment Manager EQT Group2021 - 2022

Board Member Pan Cancer T2020 - 2021

Board Member Allero Therapeutics2019 - 2021

Investment Manager Swanbridge Capital2018 - 2021

Team leader | Life Sciences Catalyze - Carrying Ideas Forward2015 - 2017

Research Fellow Massachusetts Institute of Technology (MIT)2009 - 2009